• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

序贯激素替代疗法治疗绝经后女性高胆固醇血症的疗效

Efficacy of sequential hormone replacement therapy in the treatment of hypercholesterolaemia among postmenopausal women.

作者信息

Tonstad S, Ose L, Gørbitz C, Djøseland O, Bard J M, Fruchart J C

机构信息

Medical Department A, National Hospital, Oslo, Norway.

出版信息

J Intern Med. 1995 Jul;238(1):39-47. doi: 10.1111/j.1365-2796.1995.tb00897.x.

DOI:10.1111/j.1365-2796.1995.tb00897.x
PMID:7608645
Abstract

OBJECTIVES

To test the efficacy of hormone replacement therapy (HRT) and dietary therapy, compared to dietary therapy, in lowering LDL cholesterol levels among postmenopausal women.

DESIGN

A prospective parallel randomized study of sequential 17 beta-oestradiol and norethisterone acetate or placebo for 48 weeks.

SETTING

A University outpatient lipid clinic.

SUBJECTS

A total of 76 postmenopausal women, aged 43-60 years, with LDL cholesterol levels > or = 4.2 mmol 1-1, treated with a lipid-lowering diet.

MAIN OUTCOME MEASURES

Levels of lipids, lipoproteins, apolipoproteins, fibrinogen and glucose tolerance.

RESULTS

Adherence to the diet was similar in both groups. Total and LDL cholesterol levels were reduced by 14% (95% CI, 11-17%) and 19% (95% CI, 14-23%), respectively, in the HRT group vs. 3% (95% CI, 0-7%) and 5% (95% CI, 0-11%) in the diet group. HRT reduced the levels of apolipoprotein B and lipoprotein(a). Levels of HDL cholesterol, HDL2, HDL3, triglycerides, lipoprotein populations and apolipoproteins AI and AII remained unchanged. No adverse effects on glucose tolerance or on fibrinogen levels were observed. The reduction in LDL cholesterol was positively correlated with initial levels of LDL cholesterol and negatively correlated with body mass index.

CONCLUSIONS

HRT is effective in reducing elevated LDL cholesterol levels, and should be considered in the treatment of hyperlipidaemic postmenopausal women, in addition to dietary therapy.

摘要

目的

与饮食疗法相比,测试激素替代疗法(HRT)在降低绝经后女性低密度脂蛋白胆固醇水平方面的疗效。

设计

一项前瞻性平行随机研究,连续使用17β-雌二醇和醋酸炔诺酮或安慰剂治疗48周。

地点

大学门诊脂质诊所。

研究对象

共有76名年龄在43 - 60岁之间、低密度脂蛋白胆固醇水平≥4.2 mmol/L的绝经后女性,接受降脂饮食治疗。

主要观察指标

血脂、脂蛋白、载脂蛋白、纤维蛋白原和葡萄糖耐量水平。

结果

两组对饮食的依从性相似。HRT组的总胆固醇和低密度脂蛋白胆固醇水平分别降低了14%(95%可信区间,11 - 17%)和19%(95%可信区间,14 - 23%),而饮食组分别降低了3%(95%可信区间,0 - 7%)和5%(95%可信区间,0 - 11%)。HRT降低了载脂蛋白B和脂蛋白(a)的水平。高密度脂蛋白胆固醇、HDL2、HDL3、甘油三酯、脂蛋白群体以及载脂蛋白AI和AII的水平保持不变。未观察到对葡萄糖耐量或纤维蛋白原水平有不良影响。低密度脂蛋白胆固醇的降低与初始低密度脂蛋白胆固醇水平呈正相关,与体重指数呈负相关。

结论

HRT在降低升高的低密度脂蛋白胆固醇水平方面有效,除饮食疗法外,在治疗绝经后高脂血症女性时应予以考虑。

相似文献

1
Efficacy of sequential hormone replacement therapy in the treatment of hypercholesterolaemia among postmenopausal women.序贯激素替代疗法治疗绝经后女性高胆固醇血症的疗效
J Intern Med. 1995 Jul;238(1):39-47. doi: 10.1111/j.1365-2796.1995.tb00897.x.
2
Differing effects of low-dose estrogen-progestin therapy and pravastatin in postmenopausal hypercholesterolemic women.低剂量雌激素 - 孕激素疗法与普伐他汀对绝经后高胆固醇血症女性的不同影响。
Climacteric. 2002 Dec;5(4):341-50.
3
Effects of a lipid lowering fibrate and hormone replacement therapy on serum lipids and lipoproteins in overweight postmenopausal women with elevated triglycerides.降脂贝特类药物和激素替代疗法对甘油三酯升高的超重绝经后妇女血脂和脂蛋白的影响。
Maturitas. 2002 May 20;42(1):55-62. doi: 10.1016/s0378-5122(01)00302-4.
4
Randomized trial of effects of estradiol in combination with either norethisterone acetate or trimegestone on lipids and lipoproteins in postmenopausal women.绝经后女性中,雌二醇联合醋酸炔诺酮或孕三烯酮对脂质和脂蛋白影响的随机试验。
Climacteric. 2004 Sep;7(3):292-300. doi: 10.1080/13697130400001364.
5
Effects of sequential combined transdermal and oral hormone replacement therapies on serum lipid and lipoproteins in postmenopausal women.序贯联合经皮和口服激素替代疗法对绝经后妇女血清脂质和脂蛋白的影响。
Arch Gynecol Obstet. 2002 Jan;266(1):38-43. doi: 10.1007/pl00007497.
6
Effects of continuous estrogen and estrogen-progestin replacement regimens on cardiovascular risk markers in postmenopausal women.连续雌激素和雌激素 - 孕激素替代疗法对绝经后女性心血管风险标志物的影响。
Arch Intern Med. 2000 Nov 27;160(21):3315-25. doi: 10.1001/archinte.160.21.3315.
7
Changes in lipid and lipoprotein profile in postmenopausal women receiving low-dose combinations of 17beta-estradiol and norethisterone acetate.接受低剂量17β-雌二醇与醋酸炔诺酮联合治疗的绝经后女性的血脂和脂蛋白谱变化
Menopause. 2002 Sep-Oct;9(5):335-42. doi: 10.1097/00042192-200209000-00006.
8
Effects of transdermal 17 beta-oestradiol combined with oral progestogen on lipids and lipoproteins in hypercholesterolaemic postmenopausal women.
J Intern Med. 1993 Nov;234(5):447-51. doi: 10.1111/j.1365-2796.1993.tb00776.x.
9
Effects of tibolone or continuous combined oestradiol and norethisterone acetate on lipids, high-density lipoprotein subfractions and apolipoproteins in postmenopausal women in a two-year, randomized, double-blind, placebo-controlled trial.为期两年的、随机、双盲、安慰剂对照试验中,替勃龙或连续联合雌二醇和醋酸炔诺酮对绝经后妇女的血脂、高密度脂蛋白亚组分和载脂蛋白的影响。
Clin Endocrinol (Oxf). 2020 Apr;92(4):303-311. doi: 10.1111/cen.14155. Epub 2020 Jan 28.
10
Is the response of serum lipids and lipoproteins to postmenopausal hormone replacement therapy modified by ApoE genotype?血清脂质和脂蛋白对绝经后激素替代疗法的反应是否受载脂蛋白E基因型的影响?
Arterioscler Thromb Vasc Biol. 1999 Feb;19(2):402-7. doi: 10.1161/01.atv.19.2.402.

引用本文的文献

1
Hormone replacement therapy for preventing cardiovascular disease in post-menopausal women.激素替代疗法预防绝经后女性心血管疾病
Cochrane Database Syst Rev. 2005 Apr 18(2):CD002229. doi: 10.1002/14651858.CD002229.pub2.
2
Hormone replacement therapy: optimising the dose and route of administration.激素替代疗法:优化剂量与给药途径
Drugs Aging. 2002;19(11):807-18. doi: 10.2165/00002512-200219110-00001.